Thomas M. Cunningham

Array ( [id] => 3662839 [patent_doc_number] => 05599545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Mycobacterium as adjuvant for antigens' [patent_app_type] => 1 [patent_app_number] => 8/441785 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2379 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599545.pdf [firstpage_image] =>[orig_patent_app_number] => 441785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4230831 [patent_doc_number] => 06143298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Soluble truncated forms of ICAM-1' [patent_app_type] => 1 [patent_app_number] => 8/435568 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 17756 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143298.pdf [firstpage_image] =>[orig_patent_app_number] => 435568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777005 [patent_doc_number] => 05817748 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Mimotopes of human Platelet glycoprotein Ib/IX' [patent_app_type] => 1 [patent_app_number] => 8/406330 [patent_app_country] => US [patent_app_date] => 1995-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 7 [patent_no_of_words] => 9924 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817748.pdf [firstpage_image] =>[orig_patent_app_number] => 406330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3691096 [patent_doc_number] => 05660834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates' [patent_app_type] => 1 [patent_app_number] => 8/400480 [patent_app_country] => US [patent_app_date] => 1995-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 50 [patent_no_of_words] => 20656 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/660/05660834.pdf [firstpage_image] =>[orig_patent_app_number] => 400480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883600 [patent_doc_number] => 05833989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Soluble CR1 derivatives' [patent_app_type] => 1 [patent_app_number] => 8/356361 [patent_app_country] => US [patent_app_date] => 1995-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17865 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/833/05833989.pdf [firstpage_image] =>[orig_patent_app_number] => 356361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3835075 [patent_doc_number] => 05744139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Insulin-like growth factor I (IGF-1) induced improvement of depressed T4/T8 ratios' [patent_app_type] => 1 [patent_app_number] => 8/394338 [patent_app_country] => US [patent_app_date] => 1995-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 63 [patent_no_of_words] => 20354 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744139.pdf [firstpage_image] =>[orig_patent_app_number] => 394338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664997 [patent_doc_number] => 05599692 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Antigenic polypeptides of Taenia ovis' [patent_app_type] => 1 [patent_app_number] => 8/393383 [patent_app_country] => US [patent_app_date] => 1995-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8842 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599692.pdf [firstpage_image] =>[orig_patent_app_number] => 393383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103008 [patent_doc_number] => 06022544 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry' [patent_app_type] => 1 [patent_app_number] => 8/391267 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 54 [patent_no_of_words] => 35576 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022544.pdf [firstpage_image] =>[orig_patent_app_number] => 391267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3786961 [patent_doc_number] => 05780034 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents' [patent_app_type] => 1 [patent_app_number] => 8/384454 [patent_app_country] => US [patent_app_date] => 1995-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 14399 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780034.pdf [firstpage_image] =>[orig_patent_app_number] => 384454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695653 [patent_doc_number] => 05679774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'DNA sequences of the EBV genome, recombinant DNA molecules, processes for preparing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens' [patent_app_type] => 1 [patent_app_number] => 8/380258 [patent_app_country] => US [patent_app_date] => 1995-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 86 [patent_no_of_words] => 18645 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679774.pdf [firstpage_image] =>[orig_patent_app_number] => 380258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3862130 [patent_doc_number] => 05837246 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations' [patent_app_type] => 1 [patent_app_number] => 8/376049 [patent_app_country] => US [patent_app_date] => 1995-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10220 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837246.pdf [firstpage_image] =>[orig_patent_app_number] => 376049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3696906 [patent_doc_number] => 05645837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Peptides that inhibit T cell activation and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 8/372952 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7226 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/645/05645837.pdf [firstpage_image] =>[orig_patent_app_number] => 372952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659295 [patent_doc_number] => 05648226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Isolated peptides derived from tumor rejection antigens, and their use' [patent_app_type] => 1 [patent_app_number] => 8/370648 [patent_app_country] => US [patent_app_date] => 1995-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 7961 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648226.pdf [firstpage_image] =>[orig_patent_app_number] => 370648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3842853 [patent_doc_number] => 05766593 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Anti-inflammatory CD14 peptides' [patent_app_type] => 1 [patent_app_number] => 8/366953 [patent_app_country] => US [patent_app_date] => 1994-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 17167 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766593.pdf [firstpage_image] =>[orig_patent_app_number] => 366953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3678732 [patent_doc_number] => 05632991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Antibodies specific for E-selectin and the uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/365470 [patent_app_country] => US [patent_app_date] => 1994-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15775 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/632/05632991.pdf [firstpage_image] =>[orig_patent_app_number] => 365470 [rel_patent_id] =>[rel_patent_doc_number] =>)